In this review:
Warfarin in ESKD and atrial fibrillation
Magnesium and risk of fatal MI in HD patients
Effect of nicotinamide & lanthanum carbonate on phosphate & FGF-23 levels in CKD
Does allopurinol reduce left ventricular mass in HD patients?
Genetics vs environment: associations between BMI & CKD
Preeclampsia & the risk of renal disease
Risks for technique failure within 1 year of PD
A core outcome set for trials in HD
Interventions to reduce harm associated with acute kidney injury
24h ABPM vs office BP in renal transplant patients
Plasma exchange in patients with severe ANCA-associated vasculitis
Abatacept in patients with active lupus nephritis
Is lanreotide renoprotective in later stage ADPKD?
Ferric citrate in patients with advanced CKD
Please login below to download this issue (PDF)